Finecare CA125 (New Generation) Rapid Quantitative Test Kit – 25 Tests

The Finecare CA125 New Generation Rapid Quantitative Test is a fluorescence immunoassay designed for quantitative measurement of Cancer Antigen 125 (CA125) in human whole blood, serum, or plasma using compatible Finecare FIA analyzers. CA125 is a tumor-associated biomarker widely used to support the clinical monitoring and follow-up of patients with ovarian cancer. Wondfo states that the current Finecare CA125 assay is intended to support ovarian cancer treatment monitoring and follow-up. It provides quantitative results in approximately 10 minutes. The new-generation assay uses a 75 µL sample volume and offers a measuring range of 5–700 U/mL. Key Features - New-generation Finecare CA125 assay - Quantitative Cancer Antigen 125 measurement - Fluorescence immunoassay technology - Catalog number WW14P0001 - Suitable for whole blood, serum, and plasma - 75 µL sample volume - Fast 10-minute reaction time - Measuring range: 5–700 U/mL - Designed for ovarian cancer monitoring and follow-up - CE-marked IVD product - Compatible with the Finecare FIA platform - Professional laboratory use